Effect of the PAF-receptor antagonist SM-12502 on human platelets

Inflammation

Volumn 20, Issue 1, 1996, Pages 71-85

  Koller M ^a   Hilger, R A ^a   Konig W ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 3,5 DIMETHYL 2 (3 PYRIDYL) 4 THIAZOLIDINONE; CALCIMYCIN; FLUORIDE SODIUM; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; INFLAMMATION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0030032693     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01487746     Document Type: Article

References (38)

1. WALZ, A. and M. BAGGIOLINI. 1989. Generation of neutrophil activating peptide NAP-2 from platelet basic protein or connective tissue activating peptide III through monocyte protease. J. Exp. Med. 171:449-454.
2. SPECTOR, A. A., A. G. JOEL, and S. A. MOORE. 1988. Hydroxyeicosatetraenoic acids (HETEs). Prog. Lipid. Res. 27:271-302.
3. KÖNIG, B., K.-E. JAEGER, and W. KÖNIG. 1994. Induction of inflammatory mediator release (12-hydroxy-eicosatetraenoic acid) from human platelets by Pseudomonas aeruginosa. Int. Arch Allergy. Immunol. 104:33-41.
4. KÖNIG, B., U. BERGMANN, and W. KÖNIG. 1992. Induction of inflammatory mediator release (serotonin, 12-hydroxyeicosatetraenoic acid) from human platelets by Pseudomonas aeruginosa. Infect. Immun. 60:3150-3155.
5. KÖNIG, B., and W. KÖNIG. 1993. The role of the phosphatidyl-inositol turnover in 12-hydroxyeicosatetraenoic acid generation from human platelets by Escherichia coli α-haemolysin, thrombin and fluoride. Immunology. 80:633-639.
6. NEUBER, K., R. A. HILGER, and W. KÖNIG. 1992. Differential increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis by Staphylococcus aureus. Int. Arch. Allergy. Immunol. 98:339-342.
7. 2-a in epidermis of psoriasis. Proc. Natl. Acad. Sci. U.S.A. 72:5130-5134.
8. 4 by neutrophils and platelets from patients with atopic dermatitis. Immunology. 74:689-695.
9. MARCUS, A. J., M. J. BROEKMAN, L. B. SAFIER, H. L. ULLMAN, N. ISLAM, C. N. SERHAN, L. E. RUTHERFORD, H. M. KORCHAK, and G. WEISSMANN. 1982. Formation of leukotrienes and other hydroxyacids during platelet-neutrophil interactions in vitro. Biochem. Biophys. Res. Commun. 109:130-137.
10. MARCUS, A. J., L. B. SAFIER, L. HARRIS, L. ULLMAN, M. J. BROEKMAN, N. ISLAM, T. D. OGLESBY, and R. GORMAN. 1984. 12S,20-Dihydroxy-eicosatetraenoic acid: A new eicosanoid synthesized by neutrophils from 12S-hydroxy-eicosatetraenoic acid produced by thrombin or collagen-stimulated platelets. Proc. Natl. Acad. Sci. U.S.A. 81:903-907.
11. HECKER, M., M. HAURAND, V. ULLRICH, U. DICZFALUSY, and S. HAMMARSTRÖM. 1987. Products, kinetics, and substrate specifity of homogeneous thromboxane synthase from human platelets: development of a novel enzyme assay. Arch. Biochem. Biophys. 254:124-135.
12. 2-induced platelet aggregation by lipoxygenase products of eicosaenoic acids. Biochem. Biophys. Res. Commun. 112:878-883.
13. PATSCHEKE, H. 1985. Thromboxane synthase inhibition potentiates washed platelet activation by endogenous and exogenous arachidonic acid. Biochem. Pharmacol. 34:1151-1156.
14. 2: Biosynthesis and effects on platelets. In Prostaglandins and the Cardiovascular System. J. A. Oates, editor. Raven, New York. 15-58.
15. CHESNEY, C. M., D. D. PIFER, L. W. BYERS, E. E. MAIRHEAD. 1982. Effect of platelet-activating factor (PAF) on human platelets. Blood. 59:582-585.
16. SIESS, W. 1989. Molecular mechanisms of platelet activation. Physiol. Rev. 69:58-178.
17. 4 and sulphidopeptide leukotrienes by human neutrophils. Immunology. 77:408-415.
18. HWANG, S. B., and M. H. LAM. 1991. L-659,989 - A useful probe in the detection of multiple conformational states of PAF receptors. Lipids. 26:1148-1153.
19. UCHIDA, M., N. IMANISHI, T. SUGASAWA, and S. MOROOKA. Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 1. Effect on passive anaphylactic bronchoconstriction in guinea pigs. Lipids 26:1301-1304.
20. 2 by hydroxyeicosatetraenoic acids (HETEs). A novel pharmacological mechanism for regulating free fatty acid release. Biochem. Pharmacol. 34:1571-1575.
21. HADJIAGAPIOU, C., and A. A. SPECTOR. 1986. 12-hydroxy-eicosatetraenoic acid reduces prostacyclin production by endothelial cells. Prostaglandins 31:1135-1144.
22. GORDON, J. A., and A. A. SPECTOR. 1987. Effects of 12-HETE on renal tubular epithelial cells. Am. J. Physiol. 253:C277-C285.
23. STENSON, W. F., and C. W. PARKER. 1980. Monohydroxy eicosatetraenoic acids (HETEs) induce degranulation of human neutrophils. J. Immunol. 124:2100-2104.
24. GOETZL, E. J., J. M. WOODS, R. R. GORMAN. 1977. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-S-hydroxy-5,8,10,14-eicosatetraenoic acid. J. Clin. Invest. 59:179-183.
25. GOETZL, E. J., A. R. BRASH, A. I. TAUBER, J. A. OATES, and W. C. HUBBARD. 1980. Modulation of human neutrophils function by monohydroxy-eicosatetraenoic acids. Immunology 39:491-501.
26. BAUD, L., J. HAGEGE, J. SRAER, E. RONDEAU, J. PEREZ, and R. ARDAILLOU. 1983. Reactive oxygen production by cultured rat glomerular mesangial cells during phagocytosis is associated with stimulation of lipoxygenase activity. J. Exp. Med. 158:1836-1852.
27. NACCACHE, P. H., R. I. SHA'AFI, P. BORGEAT, and E. J. GOETZL. 1981. Mono- and dihydroxyeicosatetraenoic acids alter calcium homeostasis in rabbit neutrophils. J. Clin. Invest. 67:1584-1587.
28. CORNWELL, D. G., J. J. HUTTNER, G. E. MILO, R. V. PANGANAMALA, H. M. SHARMA, and J. C. GEER. Polyunsaturated fatty acids, vitamin E, and the proliferation of aortic smooth muscle cells. Lipids 14:194-207.
29. HILGER R. A., M. KÖLLER, and W. KÖNIG. 1996. Inhibition of leukotriene formation and IL-8 release by the PAF-receptor antagonist SM-12502. Inflammation, 20:57-70.
30. 4 synthesis by a lipoxygenase inhibitor. J. Leuko. Biol. 54:269-274.
31. MARCUS, A. J., and D. P. HAJJAR. 1993. Vascular transcellular signalling. J. Lip. Res. 34:2017-2031.
32. ROLA-PLESZCYNSKI, M. 1989. Leukotrienes and the immune system. J. Lipid. Mediators. 1:149-159.
33. HORIGUCHI, J., D. SPRIGGS, K. IMAMURA, R. STONE, R. LUEBBERS, and D. KUFE. 1989. Role of arachidonic acid metabolism in transcriptional induction of tumor necrosis factor gene expression by phorbol ester. Mol. Cell. Biol. 54:269-274.
34. 4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood. 80:1004-1011.
35. MOROOKA, S., M. UCHIDA, and N. IMANISHI. 1991. Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine. Br. J. Pharmacol. 105:756-762.
36. MCDONALD, P. P., M. POULIOT, P. BORGEAT, and S. R. MCCOLL. 1993. Induction by chemokines of lipid mediator synthesis in GM-CSF-treated human neutrophils. J. Immunol. 151:6399-6409.
37. 4 and platelet-activating factor in human neutrophils. Br. J. Pharmacol. 111:852-860.
38. GOMEZ-CAMBRONERO, J., M. DURSTIN, T. F. P. MOLSKI, P. H. NACCACHE, and R. I. SHA'AFI. 1989. Calcium is necessary but not sufficient for platelet-activating factor release in human neutrophils stimulated by physiological stimuli. J. Biol. Chem. 264:21699-21704.